Toos Alblas Amaya Alvarez Hensen Arnold Ansink Joke Appelboom ...
Innovation sourcing in biopharma: Four practices to maximize success | McKinsey
The Bcl-2 inhibitor Obatoclax overcomes resistance to histone deacetylase inhibitors SAHA and LBH589 as radiosensitizers in patient-derived glioblastoma stem-like cells. - Abstract - Europe PMC
Monique Boer email address & phone number | Berghauser Pont Director and owner contact information - RocketReach
Lotte Stapper - Programmamanager - Berghauser Pont Mediagroep | LinkedIn
Journal of Neurosurgery Volume 122 Issue 3 (2015) Journals
Lotte | McKinsey & Company
The HDAC Inhibitors Scriptaid and LBH589 Combined with the Oncolytic Virus Delta24-RGD Exert Enhanced Anti-Tumor Efficacy in Patient-Derived Glioblastoma Cells | PLOS ONE
Lotte Stapper - Programmamanager - Berghauser Pont Mediagroep | LinkedIn
GRANDPRIX TV - LOTTE BERGHAUSER PONT
Lotte Stapper - Programmamanager - Berghauser Pont Mediagroep | LinkedIn
Innovation sourcing in biopharma: Four practices to maximize success | McKinsey
Lotte M E Berghauser Pont's research works | Erasmus MC, Rotterdam (Erasmus MC) and other places
Innovation sourcing in biopharma: Four practices to maximize success | McKinsey
DenkTank 2009 - Nationale Denktank
Lotte M E Berghauser Pont's research works | Erasmus MC, Rotterdam (Erasmus MC) and other places
RePub, Erasmus University Repository: Combination therapies in a patient-derived glioblastoma model
Lotte M E Berghauser Pont's research works | Erasmus MC, Rotterdam (Erasmus MC) and other places
Lotte M E Berghauser Pont's research works | Erasmus MC, Rotterdam (Erasmus MC) and other places
Self-learning: The dawn of a new biomedical R&D paradigm | McKinsey
Lotte Stapper - Programmamanager - Berghauser Pont Mediagroep | LinkedIn
Lotte Stapper - Programmamanager - Berghauser Pont Mediagroep | LinkedIn
Developing blockbuster drugs: both nature and nurture
Innovation sourcing in biopharma: Four practices to maximize success | McKinsey
